Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/25/2003US6537811 SAP-1 (Serum-response factor accessory protein-1); oligonucleotides targeted to nucleic acids encoding SAP-1; use in treatment of cancer; anti-cancer agents
03/25/2003US6537810 Methods for regulating T cell subsets by modulating transcription factor activity
03/25/2003US6537809 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
03/25/2003US6537807 Cells designated CD7+CD34-Lin-; use in treatment of genetic and infectious diseases; identification of substances to promote growth, engraftment, and differentiation of stem cells
03/25/2003US6537805 Self-deleting vectors
03/25/2003US6537804 Expression vector comprising a DNA sequence that expresses a peptide of given amino acid sequence which includes tyrosine; use in diagnosis and treatment of leukemia
03/25/2003US6537794 Chemokine
03/25/2003US6537790 Esterase genes and uses of the same
03/25/2003US6537786 Genes encoding exopolysaccharide production
03/25/2003US6537785 Methods of treating lysosomal storage diseases
03/25/2003US6537784 Self-regulated apoptosis of inflammatory cells by gene therapy
03/25/2003US6537783 Prefunctionalized nucleotide and process for amplifying a sequence using a prefunctionalized nucleotide
03/25/2003US6537781 Methods and compositions concerning canine interleukin 5
03/25/2003US6537780 Peptide for use in human therapeutic and diagnostics
03/25/2003US6537779 T7 promoter-based expression system
03/25/2003US6537778 Eukaryotic mechanosensory transduction channel
03/25/2003US6537776 Synthetic ligation reassembly in directed evolution
03/25/2003US6537775 Gene involved in cadasil, method of diagnosis and therapeutic application
03/25/2003US6537774 UPS (undecaprenyl diphosphate synthase
03/25/2003US6537773 Open reading frames; gene expression; genetic vectors; computer based storage of sequence information; use detection and diagnosis of Mycoplasma
03/25/2003US6537767 Method for screening antimycotically active substances
03/25/2003US6537765 GPR10 as a target for identifying weight modulating compounds
03/25/2003US6537764 Method of identifying inhibitors of C—C chemokine receptor 3
03/25/2003US6537763 Nucleotide sequences coding binding protein for use used in controling immune response and screening for modulators of receptor activity
03/25/2003US6537758 Recovering nucleotide sequences associated with cell proliferstion disorder; obtain cell, generate micronuclei, amplify and recover nucleotide sequences
03/25/2003US6537756 Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and Ctenocephalides SPP
03/25/2003US6537755 Nucleic acid sequence determination; apparatus for hybridization in a solution environment; use preparation of probes without use of fixed supports; larger number and types of probes; improved process kinetics
03/25/2003US6537754 Association of kinesin with sensitivity to chemotherapeutic drugs
03/25/2003US6537750 Plant regulatory elements that can be used to express various nucleic acid molecules in transgenic plants
03/25/2003US6537749 Addressable protein arrays
03/25/2003US6537746 Method for creating polynucleotide and polypeptide sequences
03/25/2003US6537594 Vaccina virus comprising cytokine and/or tumor associated antigen genes
03/25/2003US6537560 Nucleic acid sequences encoding melanoma antigens recognized by T lymphocytes and protein and peptides encoded by these sequences
03/25/2003US6537558 Methods of producing and using virulence attenuated poxR mutant bacteria
03/25/2003US6537557 Strain 341750 PDK-6
03/25/2003US6537556 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation process
03/25/2003US6537555 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
03/25/2003US6537551 Anti-tumor agent comprising salmosin as an active ingredient
03/25/2003US6537548 Detecting bovine spongiform encephalopathy
03/25/2003US6537547 Antitumor agents; side effect reduction even at high dosage
03/25/2003US6537542 Homologous recombination
03/25/2003US6537541 Implantation of HSV-TK retrovirus producer cells to destroy glioma
03/25/2003US6537540 Administering recombinant adeno-associated virus vector; polynucleotide encoding fusion polypeptide with extracellular domain of the TNF receptor and a constant domain of an IgG1 molecule
03/25/2003US6537433 Integrated microfluidics
03/25/2003CA2399569A1 Diagnostic markers and drug targets for treatment of cancer
03/25/2003CA2382249A1 Microorganisms for use in the measurement of environmental factors
03/25/2003CA2277468C Method of purifying dna in a cross-flow centrifuge
03/25/2003CA2274092C Gene-trapping construct for the identification and isolation of genes
03/25/2003CA2251262C Nucleic acid encoding a nervous tissue sodium channel
03/25/2003CA2232749C Truncated glial cell line-derived neurotrophic factor
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2173957C Novel trypanosoma cruzi antigen, and gene coding therefor; their application to the detection of chagas' disease
03/25/2003CA2125783C Methods for producing thrombin
03/25/2003CA2123108C Human neuropeptide y-y1 receptor
03/25/2003CA2083595C Method of inducing plant defense mechanisms
03/25/2003CA2083401C Identification of a novel human receptor tyrosine kinase gene
03/25/2003CA2075182C Retinoid receptor compositions and methods
03/25/2003CA2056102C Method for the production of antibodies
03/21/2003CA2404706A1 Novel mutants of the formate dehydrogenase from candida boidinii
03/20/2003WO2003023407A1 Methods of screening molecules that are used to prevent cardiovascular diseases
03/20/2003WO2003023405A1 Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders
03/20/2003WO2003023404A1 A method of diagnosis and treatment and agents useful for same
03/20/2003WO2003023398A1 Method of screening drug and method of judging significance of mutation in gene encoding transcriptional regulatory factor
03/20/2003WO2003023393A1 Receptor interacting protein 2 in development of immune response
03/20/2003WO2003023365A2 Electrochemical sensor using intercalative, redox-active moieties
03/20/2003WO2003023360A2 Methods and apparatus for conducting multiple measurements on a sample
03/20/2003WO2003023066A1 Expression profiling in the intact human heart
03/20/2003WO2003023064A1 Blueberry red ringspot virus, sequences, promoters, and uses thereof
03/20/2003WO2003023063A1 Method of judging onset risk of diabetes
03/20/2003WO2003023061A2 Reading, detection or quantification method, hybrids or complexes used in said method and the biochip using same
03/20/2003WO2003023058A2 Genetic analysis of biological samples in arrayed expanded representations of their nucleic acids
03/20/2003WO2003023057A2 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
03/20/2003WO2003023049A2 Methods of selecting 5'-capped nucleic acid molecules
03/20/2003WO2003023048A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l)
03/20/2003WO2003023042A1 Recombinant mva capable of expressing structural hcv antigens
03/20/2003WO2003023041A2 Infectious and attenuated bovine viral diarrhea virus clone; methods for their production and use
03/20/2003WO2003023040A2 Vaccinia virus mva-e3l-knockout-mutants and use thereof
03/20/2003WO2003023039A1 Method of expressing genetically modified protein carrying sugar chain having sialic acid added thereto in insect cells
03/20/2003WO2003023038A1 Isolation and use of the desiccation-specific promoter from ds2 gene
03/20/2003WO2003023037A1 Reporter gene-containing plasmid which is convertible to t-vector and the preparation method thereof
03/20/2003WO2003023036A1 Sulfated fucogalactan digesting enzyme gene
03/20/2003WO2003023035A2 Glucosyltransferases which glucosylate abscisic acid
03/20/2003WO2003023034A2 Regulation of human tau-tubulin kinase
03/20/2003WO2003023033A1 Modified monooxygenase
03/20/2003WO2003023032A2 High throughput directed evolution by rational mutagenesis
03/20/2003WO2003023030A2 Aminopeptidase
03/20/2003WO2003023028A1 Fungal glyoxal oxidases
03/20/2003WO2003023027A2 Tt virus sequences in human tumoral tissue, agent for the detection thereof and tumoral therapy
03/20/2003WO2003023026A1 Alphavirus replicon vector systems
03/20/2003WO2003023024A1 Starch synthases
03/20/2003WO2003023021A2 Methods for producing an active constituent of a pharmaceutical or a diagnostic agent in an mdck cell suspension culture
03/20/2003WO2003023018A2 A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use
03/20/2003WO2003023017A1 Method for transforming amycolatopsis sp. dsm 9991 and dsm 9992
03/20/2003WO2003023015A2 Method for expression of small antiviral rna molecules within a cell
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023011A2 Antisense modulation of ribonuclease l expression
03/20/2003WO2003023009A2 G-protein coupled receptors
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003023005A2 Antisense modulation of pka regulatory subunit rii alpha expression
03/20/2003WO2003023004A2 Antisense modulation of fibroblast growth factor receptor 3 expression
1 ... 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 ... 4023